Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ESPR will rise by +0.78% over the next 2 Weeks and hit $3.20 by Friday, July 24, 2026. In that time frame, ESPR's share price is expected to range between $3.19 and $3.22.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 24, 2026 | 3.20 | 3.21 | 3.23 |
| Jul 23, 2026 | 3.20 | 3.21 | 3.22 |
| Jul 22, 2026 | 3.20 | 3.21 | 3.22 |
| Jul 21, 2026 | 3.19 | 3.20 | 3.21 |
| Jul 20, 2026 | 3.19 | 3.20 | 3.21 |
| Jul 17, 2026 | 3.19 | 3.20 | 3.21 |
| Jul 16, 2026 | 3.18 | 3.19 | 3.20 |
| Jul 15, 2026 | 3.19 | 3.19 | 3.20 |
| Jul 14, 2026 | 3.18 | 3.19 | 3.20 |
| Jul 13, 2026 | 3.17 | 3.18 | 3.19 |
ESPR shares remained flat 0 in Monday, July 13, 2026's trading session, starting and closing at a previous close of $3.18 to move at $3.18. The stock demonstrated notable intraday movement (see ESPR's key stats for a full breakdown), fluctuating between $3.18 and $3.18, a 0 trading range. While recent weeks have seen some volatility, ESPR has managed to secure a +0.32% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 58.43M shares changing hands, 3.09M more than the previous session. This amounted to $185.81M in total market activity.
Will ESPR Continue Its Upward Trend?
According to analyst ratings and projections for ESPR, Esperion Therapeutics, Inc. shares are anticipated to increase by +1.47%, potentially reaching $3.23 per share by July 24, 2026. Short-term technical indicators currently suggest a neutral sentiment for ESPR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the ESPR stock forecast, now is a good time to buy ESPR stock because its current trading price is -1.08% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ESPR covering social and institutional perspectives.
ESPR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ESPR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 61.75% to 64.48%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 54.15%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.48%, maintains a neutral outlook for the long term. Insights into ESPR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Esperion Therapeutics, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Esperion Therapeutics, Inc. (ESPR) is positioned to show a strong performance in August 2026. The price is predicted to move between $17.10 and $18.81, settling at an average of $17.83. This could translate to a +460.69% gain.
September 2026
Based on current market signals, Esperion Therapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $16.72 to $18.31, with a likely average price of $17.48. Investors could expect a potential return of +449.69%.
October 2026
Our predictive algorithms indicate Esperion Therapeutics, Inc. stock may see a shift in October 2026. The expected range spans $17.73–$20.48, with an average target of $19.14. This represents a positive outlook and a possible gain of +501.89%.
November 2026
Analyzing established trends, Esperion Therapeutics, Inc. looks set to move in November 2026. Projections place the stock between $19.22 and $28.77, averaging around $21.92. This suggests a +589.31% gain from current levels.
December 2026
Market indicators suggest Esperion Therapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $24.17 to $30.59, with a midpoint forecast of $26.49. The stock might deliver a +733.02% gain.
January 2027
Forecasting for January 2027, models estimate that Esperion Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $15.14 and $28.28, averaging $19.93. This signals a positive trajectory with potential returns around +526.73%.
February 2027
According to our latest forecast models, Esperion Therapeutics, Inc. (ESPR) is positioned to show a strong performance in February 2027. The price is predicted to move between $14.81 and $24.73, settling at an average of $18.60. This could translate to a +484.91% gain.
March 2027
Based on current market signals, Esperion Therapeutics, Inc. is projected to trend march 2027. We forecast a trading range from $15.11 to $25.10, with a likely average price of $18.32. Investors could expect a potential return of +476.10%.
April 2027
Our predictive algorithms indicate Esperion Therapeutics, Inc. stock may see a shift in April 2027. The expected range spans $13.34–$25.29, with an average target of $17.33. This represents a positive outlook and a possible gain of +444.97%.
May 2027
Analyzing established trends, Esperion Therapeutics, Inc. looks set to move in May 2027. Projections place the stock between $15.90 and $29.54, averaging around $20.45. This suggests a +543.08% gain from current levels.
June 2027
Market indicators suggest Esperion Therapeutics, Inc. could experience notable changes during June 2027. Prices could fluctuate within $12.33 to $25.63, with a midpoint forecast of $17.39. The stock might deliver a +446.86% gain.
July 2027
Forecasting for July 2027, models estimate that Esperion Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $12.08 and $23.24, averaging $15.98. This signals a positive trajectory with potential returns around +402.52%.
ESPR's history of dividends and stock splits also plays a role in long-term investor confidence.